 Connection
Elizabeth David to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Elizabeth David has written about Carcinoma, Non-Small-Cell Lung.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.797 |
|
|
|
-
Toubat O, Ding L, Ding K, Wightman SC, Atay SM, Harano T, Kim AW, David EA. Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial. Semin Thorac Cardiovasc Surg. 2024 Summer; 36(2):261-270.
Score: 0.472
-
Bick KJ, Ding L, Ebner PJ, Kim AW, Atay SM, Wightman SC, McFadden PM, Farias AJ, David EA. Regional Variation in Treatment for Highest-Risk Patients With Non-Small Cell Lung Cancer. Ann Thorac Surg. 2022 04; 113(4):1282-1290.
Score: 0.427
-
Toubat O, Atay SM, Kim AW, Ding L, Farias AJ, Ebner PJ, McFadden PM, David EA. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2020 05; 109(5):1512-1520.
Score: 0.390
-
Ebner PJ, Ding L, Kim AW, Atay SM, Yao MJ, Toubat O, McFadden PM, Balekian AA, David EA. The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2020 01; 109(1):225-232.
Score: 0.379
-
David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ. Survival benefits associated with surgery for advanced non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1620-1628.
Score: 0.359
-
David EA, Andersen SW, Beckett LA, Melnikow J, Kelly K, Cooke DT, Brown LM, Canter RJ. A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2017 Nov; 104(5):1665-1672.
Score: 0.332
-
David EA, Clark JM, Cooke DT, Melnikow J, Kelly K, Canter RJ. The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung?Cancer. J Thorac Oncol. 2017 11; 12(11):1636-1645.
Score: 0.330
-
David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ. Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A?Propensity-Matched Analysis. J Thorac Oncol. 2017 03; 12(3):437-445.
Score: 0.317
-
David EA, Cooke DT, Chen Y, Nijar K, Canter RJ, Cress RD. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? Ann Thorac Surg. 2017 Jan; 103(1):226-235.
Score: 0.306
-
David EA, Canter RJ, Chen Y, Cooke DT, Cress RD. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. Ann Thorac Surg. 2016 Oct; 102(4):1101-9.
Score: 0.304
-
Cooke DT, Gandara DR, Goodwin NC, Calhoun RF, Lara PN, Mack PC, David EA. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):36-40.
Score: 0.260
-
Stuart CM, Dyas AR, Bronsert MR, Velopulos CG, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Effect of Social Vulnerability on Initial Stage and Treatment for Non-Small Cell Lung Cancer. Lung Cancer. 2024 02; 188:107452.
Score: 0.128
-
Dyas AR, Bronsert MR, Stuart CM, Thomas MB, Schulick RD, Franco SR, Gleisner A, Randhawa SK, David EA, Mitchell JD, Meguid RA. Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non-small cell lung cancer in the United States. J Thorac Cardiovasc Surg. 2024 Aug; 168(2):378-390.e7.
Score: 0.127
-
Kidane B, Bott M, Spicer J, Backhus L, Chaft J, Chudgar N, Colson Y, D'Amico TA, David E, Lee J, Najmeh S, Sepesi B, Shu C, Yang J, Swanson S, Stiles B. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 09; 166(3):637-654.
Score: 0.123
-
Wightman SC, Lee JY, Ding L, Atay SM, Shemanski KA, McFadden PM, David EA, Kim AW. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
Score: 0.115
-
Jang JK, Atay SM, Ding L, David EA, Wightman SC, Kim AW, Ye JC. Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung Cancer. Am J Clin Oncol. 2022 04 01; 45(4):146-154.
Score: 0.114
-
Daly ME, Singh N, Ismaila N, Antonoff MB, Arenberg DA, Bradley J, David E, Detterbeck F, Fr?h M, Gubens MA, Moore AC, Padda SK, Patel JD, Phillips T, Qin A, Robinson C, Simone CB. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. J Clin Oncol. 2022 04 20; 40(12):1356-1384.
Score: 0.111
-
Atay SM, Amini M, Ding L, David EA, Mcfadden PM, Wightman SC, Kim AW. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection. Ann Thorac Surg. 2021 07; 112(1):197-205.
Score: 0.103
-
Xu E, David EA, Ding L, Atay SM, McFadden PM, Wightman SC, Kim AW. Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer. J Surg Oncol. 2020 Aug; 122(2):320-327.
Score: 0.100
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|